DekaBank Deutsche Girozentrale
EIDX

DekaBank Deutsche Girozentrale’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,800
Closed -$1.72M – 1413
2020
Q4 		$1.72M Sell
13,800
-700
-5% -$61.9K 0.01% 702
2020
Q3 		$721K Buy
+14,500
New +$652K ﹤0.01% 848

DekaBank Deutsche Girozentrale's EIDX Position: Q1 2021 in Review

DekaBank Deutsche Girozentrale sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 13,800 shares — an estimated $1.72M sold.

DekaBank Deutsche Girozentrale first reported a position in EIDX in Q3 2020 and held it in 2 quarters. The position peaked at $1.72M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • DekaBank Deutsche Girozentrale reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 13,800 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.72M.
  • DekaBank Deutsche Girozentrale first reported a position in Eidos Therapeutics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • DekaBank Deutsche Girozentrale's Eidos Therapeutics, Inc. Common Stock position peaked at $1.72M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2021, filed 28 Apr 2021.